Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
Ferrarini, A M
Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients. [electronic resource] - Multiple sclerosis (Houndmills, Basingstoke, England) Jun 1998 - 174-7 p. digital
Publication Type: Journal Article
1352-4585
10.1177/135245859800400316 doi
Adjuvants, Immunologic--therapeutic use
Adolescent
Adult
Antigen-Antibody Reactions
Biomarkers--blood
HLA-DR Antigens--blood
Humans
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Lymphocyte Activation
Middle Aged
Multiple Sclerosis--drug therapy
Receptors, Interleukin-2--blood
Recombinant Proteins--therapeutic use
T-Lymphocytes--immunology
Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients. [electronic resource] - Multiple sclerosis (Houndmills, Basingstoke, England) Jun 1998 - 174-7 p. digital
Publication Type: Journal Article
1352-4585
10.1177/135245859800400316 doi
Adjuvants, Immunologic--therapeutic use
Adolescent
Adult
Antigen-Antibody Reactions
Biomarkers--blood
HLA-DR Antigens--blood
Humans
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Lymphocyte Activation
Middle Aged
Multiple Sclerosis--drug therapy
Receptors, Interleukin-2--blood
Recombinant Proteins--therapeutic use
T-Lymphocytes--immunology